Jianchun Mao

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.

Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.

Journal: The British journal of dermatology
Published: March 31, 2026

Osteoporosis prediction in primary Sjögren's syndrome: development and external validation of a machine-learning comparison model.

Osteoporosis prediction in primary Sjögren's syndrome: development and external validation of a machine-learning comparison model.

Journal: Rheumatology (Oxford, England)
Published: March 09, 2026

The association between night shift work and osteoporosis risk in adults: A cross-sectional analysis using NHANES.

The association between night shift work and osteoporosis risk in adults: A cross-sectional analysis using NHANES.

Journal: Heliyon
Published: October 14, 2023

Signaling pathways in rheumatoid arthritis: implications for targeted therapy.

Signaling pathways in rheumatoid arthritis: implications for targeted therapy.

Journal: Signal transduction and targeted therapy
Published: September 15, 2022

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China.

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China.

Journal: Frontiers in pharmacology
Published: May 01, 2022

STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway.

STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway.

Journal: Signal transduction and targeted therapy
Published: January 27, 2022

SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases.

SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases.

Journal: Clinical and translational medicine
Published: May 11, 2021

Neuron navigator 2 is a novel mediator of rheumatoid arthritis.

Neuron navigator 2 is a novel mediator of rheumatoid arthritis.

Journal: Cellular & molecular immunology
Published: April 28, 2021

New Therapeutic Approaches Using Hydrogen Sulfide Donors in Inflammation and Immune Response.

New Therapeutic Approaches Using Hydrogen Sulfide Donors in Inflammation and Immune Response.

Journal: Antioxidants & redox signaling
Published: April 01, 2021

NAV2 positively modulates inflammatory response of fibroblast-like synoviocytes through activating Wnt/β-catenin signaling pathway in rheumatoid arthritis.

NAV2 positively modulates inflammatory response of fibroblast-like synoviocytes through activating Wnt/β-catenin signaling pathway in rheumatoid arthritis.

Journal: Clinical and translational medicine
Published: February 17, 2021

Traditional Chinese medicine on treating active rheumatoid arthritis: A protocol for systematic review and meta-analysis.

Traditional Chinese medicine on treating active rheumatoid arthritis: A protocol for systematic review and meta-analysis.

Journal: Medicine
Published: June 17, 2020

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis.

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis.

Journal: Medicine
Published: March 19, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026